Avita Medical | 1811094D - Beneficio Bruto En Ventas

Precio De Mercado
1.20
Cambio Diario
-0.02 -1.23%
Mensual
11.63%
Anual
-60.40%
Q2 Expectativa
1.22




Beneficio Bruto En Ventas Cambio Fecha
Accuray USD 41.89M 7.42M 2024-12
Celltrion KRW 626.11B 81.75B 2025-09
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 856.8M 430M 2025-12
CSL USD 4.46B 2.71B 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Mayne Pharma AUD 86.13M 18.92M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Nanosonics AUD 78.01M 3.95M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pacific Edge NZD 5.2M 1.75M 2024-06
Paradigm Biopharmaceuticals AUD -9K 423.94K 2025-06
Pharma Mar EUR 86.7M 53.34M 2025-12
Polynovo AUD 61.26M 38M 2025-12
PYC Therapeutics AUD 5.83M 750K 2025-06
Qiagen NV USD 325.27M 19.53M 2025-12
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 886.53M 65.71M 2025-12
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Telix Pharmaceuticals AUD 217.82M 9.23M 2025-12
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06